Precision Biosciences is launching its first-in-human trial of PBGENE-HBV, its gene-editing therapy for chronic hepatitis B infections.#LiverDisease #LiverDiseaseAwareness #LiverDiseaseSupport #LiverDiseaseResearch
#LiverDisease #LiverDiseaseAwareness #LiverDiseaseSupport #LiverDiseaseResearch